Angiogenesis in the primate ovulatory follicle is stimulated by luteinizing hormone via prostaglandin E2

Biology of Reproduction

Volumn 92, Issue 1, 2015, Pages

  Trau, Heidi A ^a   Davis, John S ^b   Duffy, Diane M ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Angiogenesis; Endothelial cell; Macaque; Ovary; Ovulation; PGE2 receptor; Primates; Prostaglandins

Indexed keywords

CHORIONIC GONADOTROPIN; GONADOTROPIN; INDOMETACIN; LUTEINIZING HORMONE; PROSTAGLANDIN E RECEPTOR 1; PROSTAGLANDIN E RECEPTOR 2; PROSTAGLANDIN E2; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; VON WILLEBRAND FACTOR; PROSTAGLANDIN E RECEPTOR;

ADULT; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAPILLARY ENDOTHELIAL CELL; CELL MIGRATION; ENDOTHELIUM CELL; FEMALE; GRANULOSA CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LUTEINIZING HORMONE RELEASE; MACACA FASCICULARIS; NONHUMAN; OVARY DEVELOPMENT; OVARY FOLLICLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ANIMAL; CELL CULTURE; DRUG EFFECTS; METABOLISM; OVULATION; PHYSIOLOGY; VASCULARIZATION;

MACACA; PRIMATES;

ANIMALS; CELLS, CULTURED; DINOPROSTONE; ENDOTHELIAL CELLS; FEMALE; LUTEINIZING HORMONE; MACACA FASCICULARIS; NEOVASCULARIZATION, PHYSIOLOGIC; OVARIAN FOLLICLE; OVULATION; RECEPTORS, PROSTAGLANDIN E;

EID: 84930325722     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.114.123711     Document Type: Article

References (61)

1. Wulff C, Wilson H, Wiegand SJ, Rudge JS, Fraser HM. Prevention of thecal angiogenesis, antral follicular growth, and ovulation in the primate by treatment with vascular endothelial growth factor trap R1R2. Endocrinology 2002; 143:2797-2807.
2. Hazzard TM, Xu F, Stouffer RL. Injection of soluble vascular endothelial growth factor receptor 1 into the preovulatory follicle disrupts ovulation and subsequent luteal function in rhesus monkeys. Biol Reprod 2002; 67:1305-1312.
3. Fraser HM, Hastings JM, Allen D, Morris KD, Rudge JS, Wiegand SJ. Inhibition of delta-like ligand 4 induces luteal hypervascularization followed by functional and structural luteolysis in the primate ovary. Endocrinology 2012; 153:1972-1983.
4. Hazzard TM, Rohan RM, Molskness TA, Fanton JW, D'Amato RJ, Stouffer RL. Injection of anti-angiogenic agents into the macaque preovulatory follicle: disruption of corpus luteum development and function. Endocrine 2002; 17:199-206.
5. Xu F, Hazzard TM, Evans A, Charnock-Jones S, Smith S, Stouffer RL. Intraovarian actions of anti-angiogenic agents disrupt periovulatory events during the menstrual cycle in monkeys. Contraception 2005; 71:239-248.
6. Garside SA, Henkin J, Morris KD, Norvell SM, Thomas FH, Fraser HM. A thrombospondin-mimetic peptide, ABT-898, suppresses angiogenesis and promotes follicular atresia in pre- and early-antral follicles in vivo. Endocrinology 2010; 151:5905-5915.
7. Sirois J, Dore M. The late induction of prostaglandin G/H synthase-2 in equine preovulatory follicles supports its role as a determinant of the ovulatory process. Endocrinology 1997; 138:4427-4434.
8. Duffy DM, Stouffer RL. The ovulatory gonadotrophin surge stimulates cyclooxygenase expression and prostaglandin production by the monkey follicle. Mol Hum Reprod 2001; 7:731-739.
9. Duffy DM, Stouffer RL. Follicular administration of a cyclooxygenase inhibitor can prevent oocyte release without alteration of normal luteal function in rhesus monkeys. Hum Reprod 2002; 17:2825-2831.
10. Bos CL, Richel DJ, Ritsema T, Peppelenbosch MP, Versteeg HH. Prostanoids and prostanoid receptors in signal transduction. Int J Biochem Cell Biol 2004; 36:1187-1205.
11. Wang M, Honn KV, Nie D. Cyclooxygenases, prostanoids, and tumor progression. Cancer Metastasis Rev 2007; 26:525-534.
12. Seachord CL, VandeVoort CA, Duffy DM. Adipose-differentiation related protein: a gonadotropin- and prostaglandin-regulated protein in primate periovulatory follicles. Biol Reprod 2005; 72:1305-1314.
13. VandeVoort CA, Baughman WL, Stouffer RL. Comparison of different regimens of human gonadotropins for superovulation of rhesus monkeys: ovulatory response and subsequent luteal function. J In Vitro Fertil Embryo Transfer 1989; 6:85-91.
14. Hibbert ML, Stouffer RL, Wolf DP, Zelinski-Wooten MB. Midcycle administration of a progesterone synthesis inhibitor prevents ovulation in primates. Proc Natl Acad Sci U S A 1996; 93:1897-1901.
15. Kim SO, Harris SM, Duffy DM. Prostaglandin E2 (EP) receptors mediate PGE2-specific events in ovulation and luteinization within primate ovarian follicles. Endocrinology 2014; 155:1466-1475.
16. Sanders SL, Stouffer RL, Brannian JD. Androgen production by monkey luteal cell subpopulations at different stages of the menstrual cycle. J Clin Endocrinol Metab 1996; 81:591-596.
17. Christenson LK, Stouffer RL. Isolation and culture of microvascular endothelial cells from the primate corpus luteum. Biol Reprod 1996; 55:1397-1404.
18. Gordon J, Patel SR, Mishina Y, Manley NR. Evidence for an early role for BMP4 signaling in thymus and parathyroid morphogenesis. Dev Biol 2010; 339:141-154.
19. Duffy DM, Seachord CL, Dozier BL. An ovulatory gonadotropin stimulus increases cytosolic phospholipase A2 (cPLA2) expression and activity in granulosa cells of primate periovulatory follicles. J Clin Endocrinol Metab 2005; 90:5858-5865.
20. Markosyan N, Dozier BL, Lattanzio FA, Duffy DM. Primate granulosa cell response via prostaglandin E2 receptors increases late in the periovulatory interval. Biol Reprod 2006; 75:868-876.
21. Duffy DM, Dozier BL, Seachord CL. Prostaglandin dehydrogenase and prostaglandin levels in periovulatory follicles: implications for control of primate ovulation by PGE2. J Clin Endocrinol Metab 2005; 90:1021-1027.
22. Kim SO, Dozier BL, Kerry JA, Duffy DM. EP3 receptor isoforms are differentially expressed in subpopulations of primate granulosa cells and couple to unique G-proteins. Reproduction 2013; 146:625-635.
23. Nakatsu MN, Davis J, Hughes CC. Optimized fibrin gel bead assay for the study of angiogenesis. J Visualized Exp 2007; 3:186.
24. Acosta TJ, Miyamoto A. Vascular control of ovarian function: ovulation, corpus luteum formation and regression. Anim Reprod Sci 2004; 82-83:127-140.
25. Harris SM, Aschenbach LC, Skinner SM, Dozier BL, Duffy DM. Prostaglandin E2 receptors are differentially expressed in subpopulations of granulosa cells from primate periovulatory follicles. Biol Reprod 2011; 85:916-923.
26. Klein D, Hohn HP, Kleff V, Tilki D, Ergun S. Vascular wall-resident stem cells. Histol Histopathol 2010; 25:681-689.
27. Heinke J, Patterson C, Moser M. Life is a pattern: vascular assembly within the embryo. Front Biosci (Elite Ed) 2012; 4:2269-2288.
28. Corner GW. Development, organization, and breakdown of the corpus luteum in the rhesus monkey. Contr Embryol Carnegie Inst 1945; 31:117-146.
29. Koering MJ. Cyclic changes in ovarian morphology during the menstrual cycle in Macaca mulatta. Am J Anat 1969; 126:73-101.
30. Peters MW, Pursley JR, Smith GW. Inhibition of intrafollicular PGE2 synthesis and ovulation following ultrasound-mediated intrafollicular injection of the selective cyclooxygenase-2 inhibitor NS-398 in cattle. J Anim Sci 2004; 82:1656-1662.
31. Calder MD, Caveney AN, Sirard MA, Watson AJ. Effect of serum and cumulus cell expansion on marker gene transcripts in bovine cumulusoocyte complexes during maturation in vitro. Fertil Steril 2005; 83:1077-1085.
32. Duffy DM, McGinnis LK, VandeVoort CA, Christenson LK. Mammalian oocytes are targets for prostaglandin E2 (PGE2) action. Reprod Biol Endocrinol 2010; 8:131.
33. Bridges PJ, Fortune JE. Regulation, action and transport of prostaglandins during the periovulatory period in cattle. Mol Cell Endocrinol 2007; 263:1-9.
34. Rao R, Redha R, Macias-Perez I, Su Y, Hao C, Zent R, Breyer MD, Pozzi A. Prostaglandin E2-EP4 receptor promotes endothelial cell migration via ERK activation and angiogenesis in vivo. J Biol Chem 2007; 282:16959-16968.
35. Zhang Y, Daaka Y. PGE2 promotes angiogenesis through EP4 and PKA Cγ pathway. Blood 2011; 118:5355-5364.
36. Narumiya S, Sugimoto T, Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev 1999; 79:1193-1226.
37. Bhattacharya M, Peri K, Ribeiro-da-Silva A, Almazan G, Shichi H, Hou X, Varma DR, Chemtob S. Localization of functional prostaglandin E2 receptors EP3 and EP4 in the nuclear envelope. J Biol Chem 1999; 274:15719-15724.
38. Bhattacharya M, Varma DR, Chemtob S. Nuclear prostaglandin receptors. Gene Ther Mol Biol 1999; 4:323-338.
39. Coleman RA, Smith WL, Narumiya S VIII. International union of pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 1994; 46:205-229.
40. Giblin GM, Bit RA, Brown SH, Chaignot HM, Chowdhury A, Chessell IP, Clayton NM, Coleman T, Hall A, Hammond B, Hurst DN, Michel AD, et al. The discovery of 6-[2-(5-chloro-2-f[(2,4-difluorophenyl)-methyl]-oxygphenyl)-1-cyclopenten-1-yl]-2-pyridinecarboxylic acid, GW848687X, a potent and selective prostaglandin EP1 receptor antagonist for the treatment of inflammatory pain. Bioorg Med Chem Letters 2007; 17:385-389.
41. Forselles KJ, Root J, Clarke T, Davey D, Aughton K, Dack K, Pullen N. In vitro and in vivo characterization of PF-04418948, a novel, potent and selective prostaglandin EP2 receptor antagonist. Br J Pharmacol 2011; 164:1847-1856.
42. Kobayashi K, Murata T, Hori M, Ozaki H. Prostaglandin E2-prostanoid EP3 signal induces vascular contraction via nPKC and ROCK activation in rat mesenteric artery. Eur J Pharmacol 2011; 660:375-380.
43. Mason KL, Rogers LM, Soares EM, Bani-Hashemi T, Downward JE, Agnew D, Peters-Golden M, Weinberg JB, Crofford LJ, Aronoff DM. Intrauterine group A Streptococcal infections are exacerbated by prostaglandin E2. J Immunol 2013; 191:2457-2465.
44. Hansen-Smith FM. Capillary network patterning during angiogenesis. Clin Exp Pharmacol Physiol 2000; 27:830-835.
45. Ellinwood WE, Nett TM, Niswender GD. Ovarian vasculature: structure and function. In: Jones R (ed.), The Vertebrate Ovary. New York: Plenum Press; 1978.
46. Findlay JK. Angiogenesis in reproductive tissues. J Endocrinol 1986; 111:357-366.
47. Kaessmeyer S, Plendl J. Angiogenesis and vasculogenesis in the corpus luteum in vitro. Clinl Hemorheol Microcirc 2009; 41:83-101.
48. Zhu Z, Fu C, Li X, Song Y, Li C, Zou M, Guan Y, Zhu Y. Prostaglandin E2 promotes endothelial differentiation from bone marrow-derived cells through AMPK activation. PLoS One 2011; 6:e23554.
49. Kamiyama M, Pozzi A, Yang L, DeBusk LM, Breyer RM, Lin PC. EP2, a receptor for PGE2, regulates tumor angiogenesis through direct effects on endothelial cell motility and survival. Oncogene 2006; 25:7019-7028.
50. Gerwins P, Skoldenberg E, Claesson-Welsh L. Functions of fibroblast growth factors and vascular endothelial growth factors and their receptors in angiogenesis. Crit Rev Oncol Hematol 2000; 34:185-194.
51. Martelli A, Berardinelli P, Russo V, Mauro A, Bernabò N, Gioia L, Mattioli M, Barboni B. Spatio-temporal analysis of vascular endothelial growth factor expression and blood vessel remodelling in pig ovarian follicles during the periovulatory period. J Mol Endocrinol 2006; 36:107-119.
52. Berisha B, Schams D, Kosmann M, Amselgruber W, Einspanier R. Expression and localisation of vascular endothelial growth factor and basic fibroblast growth factor during the final growth of bovine ovarian follicles. J Endocrinol 2000; 167:371-382.
53. Castilla A, Garcia C, Cruz-Soto M, Martinez de la Escalera G, Thebault S, Clapp C. Prolactin in ovarian follicular fluid stimulates endothelial cell proliferation. J Vasc Res 2010; 47:45-53.
54. Finetti F, Donnini S, Giachetti A, Morbidelli L, Ziche M. Prostaglandin E(2) primes the angiogenic switch via a synergic interaction with the fibroblast growth factor-2 pathway. Circ Res 2009; 105:657-666.
55. Tamura K, Sakurai T, Kogo H. Relationship between prostaglandin E2 and vascular endothelial growth factor (VEGF) in angiogenesis in human vascular endothelial cells. Vasc Pharmacol 2006; 44:411-416.
56. Daniel TO, Liu H, Morrow JD, Crews BC, Marnett LJ. Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis. Cancer Res 1999; 59:4574-4577.
57. Malinda KM, Sidhu GS, Banaudha KK, Gaddipati JP, Maheshwari RK, Goldstein AL, Kleinman HK. Thymosin α1 stimulates endothelial cell migration, angiogenesis, and wound healing. J Immunol 1998; 160:1001-1006.
58. Zou L, Cao S, Kang N, Huebert RC, Shah VH. Fibronectin induces endothelial cell migration through β1 integrin and Src-dependent phosphorylation of fibroblast growth factor receptor-1 at tyrosines 653/654 and 766. J Biol Chem 2012; 287:7190-7202.
59. Herbert SP, Stainier DYR. Molecular control of endothelial cell behaviour during blood vessel morphogenesis. Nat Rev 2011; 12:551-564.
60. Markosyan N, Duffy DM. Prostaglandin E2 acts via multiple receptors to regulate plasminogen-dependent proteolysis in the primate periovulatory follicle. Endocrinology 2009; 150:435-444.
61. Sakurai T, Suzuki K, Yoshie M, Hashimoto K, Tachikawa E, Tamura K. Stimulation of tube formation mediated through the prostaglandin EP2 receptor in rat luteal endothelial cells. J Endocrinol 2011; 209:33-43.